Biotech | March 23, 2022
Arum Therapeutics implements CDD Vault to streamline research data
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
The first-of-its-kind unique centre will increase access to preventive & primary care
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
As part of this partnership, Huma and AstraZeneca will launch Software as a Medical Device (SaMD) companion apps targeted at several therapeutic areas and will partner to help accelerate the adoption of decentralized clinical trials
This announcement comes after the formation of a new Intercontinental Region within GE Healthcare, led by Chaillot
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Building the future of food in the birthplace of cell-cultured milk
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Subscribe To Our Newsletter & Stay Updated
